Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.


Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 8 2 2019
medline: 10 5 2020
entrez: 8 2 2019
Statut: ppublish

Résumé

The 6th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in Rotterdam, Netherlands, 26-29 September, 2018. This summary manuscript is a perspective on the presentations from the plenary scientific sessions, including wellness and survivorship, B-cell NHL, AYA lymphoma, translational NHL biology, lymphoma immunology, bone marrow transplantation and cell therapy, T/Natural Killer cell lymphoma, anaplastic large cell lymphoma, lymphoblastic lymphoma, novel lymphoma therapeutics and Hodgkin lymphoma. The symposium was attended by over 260 registrants from 42 different countries and included young, middle and senior investigators. Finally, the Angelo Rosolen, MD, Memorial Lecture was delivered by Alfred Reiter, MD.

Identifiants

pubmed: 30729513
doi: 10.1111/bjh.15764
pmc: PMC6897376
mid: NIHMS1061003
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1021-1042

Subventions

Organisme : NCI NIH HHS
ID : R13 CA171748
Pays : United States
Organisme : NCI NIH HHS
ID : R13 CA232383
Pays : United States

Informations de copyright

© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Références

Br J Haematol. 2016 May;173(4):507-30
pubmed: 27133800
J Clin Oncol. 2015 Jun 20;33(18):2106-11
pubmed: 25940725
Blood. 2017 Jun 8;129(23):3071-3073
pubmed: 28356247
Oncoimmunology. 2018 Oct 11;8(1):e1512455
pubmed: 30546948
Nat Commun. 2016 Jan 12;7:10087
pubmed: 26753883
J Clin Oncol. 2015 Jun 20;33(18):2112-8
pubmed: 25940716
Br J Haematol. 2016 May;173(4):531-44
pubmed: 26996160
Leukemia. 2013 Aug;27(8):1751-3
pubmed: 23307032
Leukemia. 2016 Apr;30(4):970-3
pubmed: 26216196
Blood. 2017 Jul 20;130(3):323-327
pubmed: 28533310
Blood. 2007 Jul 15;110(2):670-7
pubmed: 17392503
Lancet. 2017 Dec 9;390(10112):2569-2582
pubmed: 28890157
Leukemia. 2015 Feb;29(2):448-55
pubmed: 24938649
J Clin Oncol. 2009 Jul 20;27(21):3533-9
pubmed: 19546402
J Clin Oncol. 2009 Feb 20;27(6):897-903
pubmed: 19139435
J Clin Oncol. 2011 Aug 1;29(22):3065-71
pubmed: 21709186
Oncotarget. 2017 Sep 06;8(45):80073-80082
pubmed: 29108389
Eur J Cancer. 2009 Apr;45(6):992-1005
pubmed: 19231160
Cancer. 2018 Jan 15;124(2):417-425
pubmed: 28915338
J Clin Oncol. 2017 Jan;35(1):32-39
pubmed: 28034070
Blood. 2008 Apr 15;111(8):4014-21
pubmed: 18258798
Cancer Cell. 2017 Jun 12;31(6):833-843.e5
pubmed: 28552327
Adv Hematol. 2009;2009:412163
pubmed: 19890467
Oncotarget. 2017 Dec 9;8(69):113895-113909
pubmed: 29371955
Br J Haematol. 2016 May;173(4):617-24
pubmed: 27009921
N Engl J Med. 2018 Jan 25;378(4):331-344
pubmed: 29224502
N Engl J Med. 2010 Nov 4;363(19):1812-21
pubmed: 21047225
Blood. 2018 Dec 13;132(24):2564-2574
pubmed: 30257881
Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):6581-6586
pubmed: 28607076
Br J Haematol. 2014 Nov;167(3):394-401
pubmed: 25066629
Leukemia. 2013 Jun;27(6):1394-7
pubmed: 23183430
Nat Genet. 2015 Nov;47(11):1316-1325
pubmed: 26437030
Haematologica. 2017 Dec;102(12):2086-2096
pubmed: 28983060
Oncogene. 2015 Apr 2;34(14):1843-52
pubmed: 24814516
Lancet Haematol. 2016 Feb;3(2):e87-98
pubmed: 26853648
Semin Oncol. 2009 Oct;36(5):381-418
pubmed: 19835736
Cancer. 2001 Oct 1;92(7):1959-66
pubmed: 11745271
N Engl J Med. 2006 Oct 12;355(15):1572-82
pubmed: 17035650
Blood. 2016 Aug 25;128(8):1101-11
pubmed: 27257180
Br J Haematol. 2005 Oct;131(1):39-49
pubmed: 16173961
Blood. 2017 Apr 27;129(17):2437-2442
pubmed: 28188133
Clin Cancer Res. 2017 Apr 1;23(7):1623-1626
pubmed: 27881581
J Clin Oncol. 2017 Oct 1;35(28):3215-3221
pubmed: 28787259
Leukemia. 2013 Apr;27(5):1174-7
pubmed: 22940833
Br J Haematol. 2016 May;173(4):573-81
pubmed: 26992145
Br J Haematol. 2013 Sep;162(6):792-801
pubmed: 23889312
Lancet Haematol. 2018 Oct;5(10):e450-e461
pubmed: 30290902
Cancer Cell. 2012 Sep 11;22(3):359-72
pubmed: 22975378
Br J Haematol. 2019 Apr;185(2):374-377
pubmed: 30117142
Leuk Lymphoma. 2023 Jan;64(1):234-237
pubmed: 36260003
Blood. 2005 May 15;105(10):3768-85
pubmed: 15692063
J Clin Oncol. 2010 Jul 1;28(19):3115-21
pubmed: 20516455
J Clin Oncol. 2015 Sep 20;33(27):2963-74
pubmed: 26304908
Pediatr Blood Cancer. 2019 Jan;66(1):e27407
pubmed: 30124231
Pediatr Blood Cancer. 2018 Aug;65(8):e27073
pubmed: 29741220
Clin Cancer Res. 2013 Jul 1;19(13):3462-73
pubmed: 23674495
Br J Haematol. 2016 May;173(4):560-72
pubmed: 26913827
Blood. 2016 Feb 18;127(7):869-81
pubmed: 26702065
Cancer. 2017 Sep 1;123(17):3326-3334
pubmed: 28464214
Cancer Treat Rev. 2010 Jun;36(4):328-34
pubmed: 20231057
Blood. 2007 Apr 1;109(7):2773-80
pubmed: 17132719
J Clin Oncol. 2018 Apr 1;36(10):942-950
pubmed: 29394125
Blood. 2011 Jul 7;118(1):139-47
pubmed: 21487109
Nat Rev Clin Oncol. 2017 Aug;14(8):497-507
pubmed: 28508875
J Clin Oncol. 2016 Aug 10;34(23):2690-7
pubmed: 27069084
Pediatr Blood Cancer. 2017 Jul;64(7):
pubmed: 27957801
J Clin Oncol. 2013 Dec 1;31(34):4333-42
pubmed: 24166518
Blood. 2012 May 3;119(18):4123-8
pubmed: 22371887
Br J Haematol. 2018 Sep;182(6):859-869
pubmed: 29984828
Prog Tumor Res. 2016;43:101-14
pubmed: 27595360
N Engl J Med. 2016 Mar 3;374(9):833-42
pubmed: 26761625
J Clin Oncol. 2011 May 1;29(13):1779-84
pubmed: 21422413
Pediatr Blood Cancer. 2012 Dec 15;59(7):1229-33
pubmed: 22488718
J Clin Oncol. 2009 Jul 10;27(20):3363-9
pubmed: 19433688
J Clin Oncol. 2011 Dec 10;29(35):4669-76
pubmed: 22084369
N Engl J Med. 2015 Jan 22;372(4):311-9
pubmed: 25482239
J Clin Oncol. 2018 Oct 1;36(28):2845-2853
pubmed: 30125215

Auteurs

Mitchell S Cairo (MS)

Departments of Pediatrics, Medicine, Pathology, Microbiology& Immunology, and Cell Biology & Anatomy, New York Medical College, Valhalla, NY, USA.

Auke Beishuizen (A)

Division of Paediatric Haemato-Oncology, Princess Maxima Centre for Paediatric Oncology, Utrecht, The Netherlands.
Department of Paediatric Oncology/Haematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH